Ausman family thankful for recoveries, support from family and community – Chippewa Herald

Paul Ausman and Raquel Hoepner-Ausman suffered traumatic brain injuries 16 days apart in April 2017. Two-and-a-half years later, both Paul and Raquel are on the comeback trail.

Paul Ausman was never shy about throwing a curveball during his days as a professional baseball pitcher.

But Ausman and his family have seen more curveballs in recent years than many families see in a lifetime.

After both Paul and his wife suffered significant brain ailments 16 days apart in April 2017, theyve continued battling and two-and-a-half years later they and their family are on the comeback trail.

While their road to recovery is far from over, they move into Thanksgiving improving every day with plenty to be thankful for.

Raquel and Paul's injuries came when their son Andrew (center) was a senior at McDonell. Andrew is now a junior at UW-Eau Claire.

Sixteen days

Raquel Hoepner-Ausman worked at Macys in Oakwood Mall for 26 years until the store closed in March 2017. A month later she collapsed after suffering a brain aneurysm in her familys home in Chippewa Falls and was taken to HSHS Sacred Heart Hospital in Eau Claire before being airlifted to Regions Hospital in St. Paul, Minnesota.

A little more than two weeks later, Paul was taken to the emergency room at HSHS St. Josephs Hospital in Chippewa Falls being before taken to Regions and diagnosed with having a brain tumor the size of a golf ball.

Both Paul and Raquel faced grueling recovery roads as their daughter Nikki lived in the Minneapolis with her family and a full-time job, and their younger son Andrew was finishing his senior year at McDonell.

A day after being admitted into Regions, Paul had a brain biopsy and was diagnosed with Lymphoma of the brain, and on May 4, 2017, had surgery for an enlarged lymph node.

Pauls vocal cord was accidentally nicked during the procedure and he lost his voice and could barely talk. The beginning of the same month, Raquel was transferred to a long-term care hospital in St. Paul and started to relearn to speak, eat and respond to commands.

She was later moved to a nursing home in Bloomer before needing brain surgery less than a year later to repair a blood vessel in her brain and had to start the process of relearning to eat, speak and respond to commands all over again.

Paul was approved for stem cell therapy and underwent his first attempt at a stem cell transplant on Sept. 28, 2017, in Rochester, Minn.

However, less than a month later, Paul was diagnosed with lymphoma cancer in both eyes, putting the stem cell transplant on hold while multiple surgeries were performed in both eyes to attempt to remove cancer cells. Follow-up chemotherapy injections into his eyes were performed until the start of the stem cell procedure, which he was able to restart in February 2018.

Paul was discharged from the stem cell transplant hospital on March 27, 2018, one day before Raquel had her brain surgery.

Raquel moved to the Rutledge home in Chippewa Falls in early June, across the street from the Ausman home, where she currently resides and rehabilitates.

Paul continued to receive chemotherapy shots in his eyes to keep the lymphoma in remission and recently has moved to a daily pill. Paul still makes monthly trips to Rochester as his body rebuilds its immune system.

B.A.T.

Paul graduated from Eau Claire Regis High School and was drafted in the 14th round of the 1973 Major League Baseball amateur draft by the Milwaukee Brewers. He played in the minor leagues for five seasons with the Brewers and Minnesota Twins, compiling a 2.93 earned run average across 147 games and 276 innings.

He reached as high as AAA with the Twins and nearly cracked the big league roster as the final cut during spring training.

The left hander shared the field with future Hall of Famers such as Robin Yount, Dave Winfield, Jack Morris, Rod Carew, Alan Trammel and Bert Blyleven before his career was finished after the 1977 season.

Paul would return to the area and earn his bachelor degree at the University of Wisconsin-Eau Claire before getting his masters from the University of Iowa.

He worked a number of jobs in the area, most recently as a store manager for the Mega Holiday station near the Family Fare grocery store downtown in Chippewa Falls.

When the Ausman family needed help, it came from a familiar face to the Chippewa Falls baseball community.

In the days and months after Paul and Raquel suffered their initial ailments, medical bills started piling up, as did the stress of figuring out how to take care of the bills. The family researched grants that could help them with their mounting medical costs, but nothing they found would shoulder the load.

Thats when Joe Vavra came into play.

The Chippewa Falls native and longtime MLB coach met Ausman after Vavra was drafted by the Los Angeles Dodgers in the eighth round of the 1982 draft.

We can't do it without you. Support local journalism with our BEST DEAL EVER!

Please call 877-782-0193 to upgrade your subscription.

Read the rest here:
Ausman family thankful for recoveries, support from family and community - Chippewa Herald

How the Packers’ Za’Darius Smith brought joy and awareness to one woman’s cancer fight – The Athletic

Eileen Booker sat in her Southern California home last Sunday night, watching the Packers game like she does every week.

She grew up in Green Bay, and her sister still lives there. Her parents bought season tickets in 1957 and her father never missed a home game. She remembers sticking to frigid metal bleachers as a kid until the clock showed zeroes in the fourth quarter, win or lose, and always burning her lips with hot chocolate.

Still a die-hard fan today, Eileen was glued to her television for a prime-time game between the Packers and 49ers, even as her favorite team trailed, 10-0, early in the second quarter.

She had no idea her name was about to be plastered on TV screens across America.

After Packers outside linebacker ZaDarius Smith sacked 49ers quarterback Jimmy Garoppolo deep in 49ers territory, he immediately found the nearest camera and lifted his jersey, revealing a white undershirt that read, WE ...

See original here:
How the Packers' Za'Darius Smith brought joy and awareness to one woman's cancer fight - The Athletic

2nd Edition Africa Healthcare Extension Summit And Africa Women’s Health Summit Starts Today In Nairobi – Africa.com

The 2nd Edition Africa Healthcare Extension Summit and Africa Womens Health Summit launches today in Nairobi, Kenya, the leading event is organized by Verve Management UAE, and will be held over two days with participation of government officials from Ministries of Health across Africa, Regulatory Bodies, Healthcare Associations, stakeholders, Doctors, Obstetricians, Gynaecologists, Reproductive Medicine Specialists, Infertility Specialists and all other Medical Professionals.

AHES and AWHS is under the patronage of Ministries of Health Malawi, Zambia, Lesotho, Zimbabwe, Eswatini and being supported by Africa Healthcare Federation, Kenya Healthcare Federation and many more!

Key topics were discussed by industry professionals during the AHES sessions which included Role of Innovation in Augmenting healthcare, Healthcare Financing Systems in Africa, Alternative Forms of Healthcare Partnerships, Medical Devices Management Policy, Innovations & Changes in Cancer Therapy and Improving patient safety & quality in healthcare.

In healthcare, business as usual is not good enough, it will not achieve the goals we have set ourselves. So, we need innovation. But what is innovation exactly and how do we ensure that healthcare innovations have impact? I will be exploring these issues using my experience towards achieving a global impact in the treatment of diarrhoea in children. says, Simon Berry of ColaLife.

Very informative and networked conference that brings decision makers and projects together. An excellent opportunity for participants to understand key healthcare issues in the region while meeting key policy and decision makers. says, Salim Hasham of Health Services International.

AWHS topics includes Interventions in Obesity Management for Women, Current trends in the treatment of Polycrystic Ovary Syndrome, Understanding Endometriosis, Stem cells and other cell-based therapies. AWHS 2019 Eminent Speakers includes: Dr. Maureen Owiti (Kenyatta National Hospital), Dr. Navin Chander Raina (M.P. Shah Hospital), Dr. Elizabeth Gitau (Kenya Medical Association), Dr. Elizabeth Nakiyingi (Womens Hospital International and Fertility Centre) and many more!

AHES and AWHS 2019 is also grateful to this years sponsors: Varian Medical Systems, Vezeeta, Adwia, Boston Scientific, Renata Limited and Sukraa Software Solution.

Originally posted here:
2nd Edition Africa Healthcare Extension Summit And Africa Women's Health Summit Starts Today In Nairobi - Africa.com

Thalassemia Treatment Market With Top Countries Data : Analysis and by Recent Trends and Regional Growth Overview Forecast 2026 – News Description

Transparency Market Research (TMR)has published a new report titled, Thalassemia Treatment Market Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 20182026.According to the report, theglobal thalassemia treatment marketwas valued at US$ 842.0 Mn in 2017 and is projected to expand at a CAGR of 7.9% from 2018 to 2026. Increase in R&D investment by key players for developing new drugs for treating thalassemia and rise in demand for chelating therapy are anticipated to fuel the growth of the global market from 2018 to 2026. Asia Pacific and Middle East & Africa are expected to dominate the global market owing to increase in prevalence of thalassemia disorder and high adoption of chelation therapy & blood transfusion for treatment by doctors as well as patients. The market in Asia Pacific is projected to expand at the fastest CAGR during the forecast period. Growth of the market in the region is attributed to large base of private clinics and hospitals, rise in number of thalassemia population requiring chelation therapy services after spleen surgery, and surge in adoption of blood transfusion among patients. The thalassemia treatment market in Latin America is likely to expand at a moderate growth rate during the forecast period.

Value Added Features in Thalassemia Treatments to Propel Global Market

The global thalassemia treatment market is projected to be driven by value added features offered by various thalassemia drug manufacturing companies in order to streamline the day to day work flow and increase revenue. The thalassemia treatment provides limited range of features and benefits ranging from patient pain heeling remedies to treatment procedures. For instance, very less number of people go for the much beneficial chelation therapy. These features help physicians and nurses to streamline the chelation therapy required for patients to maintain their daily workflow efficiently and effectively. Key players offering thalassemia treatment are coming up with value added features such as bone marrow transplantation, stem cell regeneration, gene editing methodologies, and effective modality features used for drug manufacturing along with creating a prominent candidate molecule for drugs. These features can reduce the overall operating cost and improve the overall effectiveness and efficiency of treatment practices. Companies are focusing on the development of combined drug therapy in their system to effectively integrate chelating therapy or other treatment procedure at an affordable cost. These value added features save time for physicians and help improve thalassemia patient survival performance.

Chelation Therapy to be Highly Lucrative Segment

Traditionally, blood transfusion based on type of thalassemia treatment was the most commonly used procedure among thalassemia patients. This treatment type was associated with availability of donor and cost of treatment procedure. Moreover, chelation therapy based on thalassemia treatment are priced on perpetual license model and are expensive. Chelation therapy treatment enables patients to practice intensive therapy to treat acute iron overload leading to 90% recovery among thalassemia patients. These chelation therapy based treatments address specific challenges faced during the treatment procedure. The chelation therapy treatment facilitates benefits such as pain relief, and increase in motion of blood flow among patients.

Request a PDF Brochure For the Thalassemia Treatment Market Report @https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=44462

Asia Pacific Presents Significant Opportunities

North America and Europe accounted for major share of the global thalassemia treatment market in 2017 and are likely to gain market shares by 2026. High rate of immigration from tropical regions, increasing health care budgets by governments, and government initiatives to promote thalassemia treatment technique contributed to the leading share of these regions. Asia Pacific is projected to be the most attractive market for thalassemia treatment, with highest attractiveness index. The market in Asia Pacific is expected to expand at a high CAGR of 9% during the forecast period due to large number of thalassemia patients opting for chelation therapy in developing countries such as India and China. Well-established health care facilities, medical tourism for treatment of thalassemia, and high adoption of blood transfusion safety technique in countries such as Turkey and GCC Countries are likely to drive the market in Middle East & Africa. The market in Latin America is poised to expand at a moderate growth rate during the forecast period.

Trend of R&D among Leading Players to Increase Geographic Presence

The report also provides profiles of leading players operating in the global thalassemia treatment market. bluebird bio, Inc., Acceleron Pharma, Inc., Novartis AG, Celgene Corporation, and Shire plc (Takeda Pharmaceuticals) are the leading players operating in the global market. Companies operating in the thalassemia treatment market aim to increase geographic presence and research & development through strategic acquisitions and collaborations with leading players in respective domains and region. In December 2017, Shire plc committed to pay approximately US$ 1,409.9 Mn to contract vendors for administering and executing clinical trials. Other prominent players operating in the global thalassemia treatment include Incyte Corporation, Kiadis Pharma, Gamida Cell, Celgene Corporation, and Bellicum Pharmaceuticals.

Go here to see the original:
Thalassemia Treatment Market With Top Countries Data : Analysis and by Recent Trends and Regional Growth Overview Forecast 2026 - News Description

Diabetic foot wounds kill millions, but high-tech solutions and teamwork are making a difference – Thehour.com

(The Conversation is an independent and nonprofit source of news, analysis and commentary from academic experts.)

David G. Armstrong, University of Southern California

(THE CONVERSATION) What if someone told you that theres a disease you could catch where you couldnt feel any symptoms coming on? And that this occurs every 1.2 seconds somewhere in the world?

What if you were stricken with this disease then there would be a 5% chance youd lose a limb within a year and a 50-70% chance youd be dead in five years? What if you were told that this problem cost more than the five most expensive cancers in the U.S. but far less than one one-thousandth of comparative federal and private funding is spent on attacking it?

Ladies and gentlemen, please allow me to introduce you to the humble diabetic foot ulcer. While the problem may strike at the end of the body, far away from the heart or the brain, its effects are far-reaching.

I have spent my career treating and researching the lower extremity complications of diabetes. Based on my research and experience, I believe our society could eliminate immeasurable suffering if we collectively paid more attention to this problem.

How do diabetic foot ulcers occur?

OK, I know this isnt a sexy topic. Foot wounds are ugly. Many people who have them are poor. But bear with me. They are a reality for far too many Americans and people across the globe. The ages of these patients are bimodal, in that there is one population of people who are old and getting older. Conversely, with more and more people being diagnosed with Type 2 diabetes earlier, there is a population that is younger than ever being afflicted with wounds, infections and amputation. Ignoring the problem is an example of ignoring the needs of a silent and vulnerable population.

About 31 million people in the U.S. have diabetes, and about half a billion worldwide.

Diabetic foot ulcers develop because people with diabetes slowly lose the gift of pain. Over many years, people with diabetes lose feeling in their extremities. This occurs first and generally most profoundly in their feet.

Once this occurs, people with diabetes might wear a hole in their foot, just as you or I might wear a hole in a sock or shoe. This hole is called a diabetic foot ulcer.

About half the time, the ulcer will become infected. This increases the risk of further tissue damage and, in the face of frequent vascular disease, high-level amputation. Often all of this occurs with few, if any, symptoms until it is too late.

Solutions and hope

There is also good news. Studies have suggested that high-level amputations seem to decrease when interdisciplinary care is in place, regardless of the country.

Interdisciplinary teams consist of podiatric and vascular surgeons, the so-called Toe and Flow model. The concept is simple; these two specialists, can manage a great deal of the medical, surgical and biomechanical aspects of healing and aftercare.

When we add core physical therapy to this, then the threesome (what we in the field call Toe, Flow and Go) is really quite formidable. For example, our clinics at the University of Southern California and Rancho Los Amigos in Los Angeles have active participation from more than eight specialists ranging from plastic surgery to prosthetics/orthotics, to occupational therapy to nutrition to general practice to infectious disease to diabetology to nurse case management.

Truly, it takes a village to preserve a limb.

Smart boots, high-tech vacuums and sheets of stems cells

It has long been said in wound care that its not what one puts on a wound that heals it, but what one takes off. That maxim is absolutely true in the diabetic foot. Protection of the wound is key.

The gold standard for protecting the wound has been, believe it or not, to put the patient into a special cast. This device works so well because it protects the foot in a process known as offloading, or taking the burden off the foot. By its design, this cast is not easy to remove.

While this has been my personal favorite device to heal these foot wounds, patients dont like it and most doctors dont, either. In fact, fewer than 2% of centers in the country use this as their primary means of offloading. Reasons for this include fear of putting an open wound into a cast (even though the data largely refute this), the time required to apply and remove it and patients being miserable in a hot and heavy device.

Very recently, tech company offshoots have begun to partner with prosthetic/orthotic companies to create next-gen devices that can coax patients into wearing their protective device rather than forcing it upon them. They are using phone calls and a smartwatch.

After focusing on offloading pressure, the next question is what can be done to heal the wound.

Technologies ranging from fancy vacuums, to donated placental tissue, to repurposing blood cells into a dressing to topical oxygen systems have shown recent promise. Active research is being conducted with stem cell sheets consisting of specialized cells seeded on a clear sheet, spread-on skin, and gene therapy.

Remission

As challenging as healing the wound heals, the real challenge is whats next. Following healing, 40% of foot wounds will recur in one year, about two-thirds at three years, and nearly three out of four at five years.

At USC, along with colleagues in the National Health Service in the U.K., we have developed remission clinics designed to extend and promote an active life for this high-risk patient population.

This has also been combined with things like smart insoles, socks and home-based bathmats that can identify wounds before they occur. These technologies will likely initially be subscription-based but may expand beyond that.

Diabetic foot ulcers are common, complex and costly. Theyre sinister in that they come on quietly. Perhaps, though, it is now up to us to alert our own families, communities and leaders to this condition. It is, I believe, only by teaming up that we can stem the tide and preserve not only limbs, but extend lifespan, healthspan and hope.

[ Youre smart and curious about the world. So are The Conversations authors and editors. You can read us daily by subscribing to our newsletter. ]

This article is republished from The Conversation under a Creative Commons license. Read the original article here: http://theconversation.com/diabetic-foot-wounds-kill-millions-but-high-tech-solutions-and-teamwork-are-making-a-difference-127218.

See more here:
Diabetic foot wounds kill millions, but high-tech solutions and teamwork are making a difference - Thehour.com

Stem Cells Doctors | Regenerative Medicine | Stem Cell …

Regenerative medicine, the most recent and emerging branch of medical science, deals with functional restoration of tissues or organs for the patient suffering from severe injuries or chronic diseaseconditions, in the state where bodies own regenerative responses do not suffice

The spectacular progress in the field of stem cell research has laid the foundation for cell based therapies of disease which cannot be cured by conventional medicines. The indefinite self-renewal and potential to differentiate into other types of cells represent stem cells as frontiers of regenerative medicine.

The Center for Regenerative Medicine takes three interrelated approaches:

View post:
Stem Cells Doctors | Regenerative Medicine | Stem Cell ...

Intermountain to open new center for pediatric precision medicine – Healthcare IT News

Intermountain Primary Children's Hospital, along with University of Utah Health, and Intermountain Precision Genomics are teaming up to launch a pediatric center for personalized medicine that will serve the Intermountain West.

WHY IT MATTERS The center will use precision genomics to discover, address and treat genetic diseases, many of which affect infants and children and can cause life-long disability.

The Center will focus on precision diagnosis, gene therapies and novel therapeutics, and stem cell, immunologic and regenerative medicine.

Precision medicine includes applications across diagnostics, prevention and screening that takes into account individual variabilities in genes, environment, and lifestyle for every individual.

Through its work on precision diagnosis, the Center hopes to provide more targeted care to critically-ill children based on their genetic make-up, where rapid whole genome sequencing can quickly identify genetic causes of hard-to-diagnose diseases.

The initial efforts will be focused on providing answers to critically ill infants in the newborn intensive care unit, and children with severe seizures and heart conditions.

The research into gene therapies and novel therapeutics will help enable children with previously debilitating and fatal genetic diseases, with clinical trials testing gene therapy treatments for Duchenne's Muscular Dystrophy, Adrenoleukodystrophy, and other serious diseases.

The Center is also developing novel therapeutics that target specific diseases and improve health, with a release noting the Center is one of only six hospitals nationwide to provide gene therapy for the common childhood genetic condition spinal muscular atrophy.

Stem cell research uses a child's own cells, or genetically modifies a child's cells and immune system, to fight disease and promote healing, with additional research aimed at developing immunotherapy as a tool to fight pediatric brain tumors.

The organization also noted clinical trials are testing the use of stem cells in repairing diseased hearts and other tissues.

THE LARGER TRENDIntermountain has been busy on this front recently. In June, the health system announced that it is performing a massive clinical DNA study, pairing 500,000 samples drawn from Intermountain Healths patient population and analyzing them with help from deCODE, a subsidiary of Reykjavik-based Amgen.

"Better health and being able to cure common diseases is the promise of precision medicine, but its not happening fast enough," said Dr. Marc Harrison, president and CEO at Intermountain Healthcare, announcing that initiative. "For too long, the genetic code to better health has been locked. This collaboration with deCODE unlocks that insight so we can rapidly advance well-being not only for ourselves and our families, but for generations to come.

Intermountain's new pediatrics personalized medicine announcement also follows Mount Sinai's just-announced plans to build new precision medicine supercomputer, which will have 15 terabytes of memory, 14 petabytes of raw storage and a peak speed of 220 teraflops per second, to manage massive amounts of genomic data.

ON THE RECORD"Our mission is to leverage the expertise of our scientists, the clinical care of our physicians and care-givers, and the dedication of our community, to discover and develop new cures for children," said Dr. Josh Bonkowsky, Intermountain's medical director of the Primary Children's Center for Personalized Medicine, in a statement. "The work we are doing here and now is transforming pediatric medicine. We will not be done until we have put these diseases out of business."

Nathan Eddy is a healthcare and technology freelancer based in Berlin.Email the writer:nathaneddy@gmail.comTwitter:@dropdeaded209

Healthcare IT News is a publication of HIMSS Media.

See more here:
Intermountain to open new center for pediatric precision medicine - Healthcare IT News

Discover The Latest Frontier in Anti-aging Medicine and 3 Regenerative Therapies You Should Know… – YourObserver.com

Regenerative Medicine and Stem Cell technologies... All Hype? Or The Future of Anti-Aging?

We have entered into the rapidly evolving age of Regenerative Medicine, using breakthroughs in cell to cell communication to reset your body's natural ability to heal and repair itself. Advances in Stem Cell technology race forward at an ever increasing rate as people just like you are demanding non-surgical alternatives to the multiple degenerative conditions of aging and inflammation.

If you are asking What is a Stem Cell?

Think of them as simply the master cells of rebuilding the body. They are the building blocks of our genetic code and cellular programming that coordinate healing through bio-signaling to restore our innate capacity of repair & regeneration.

Regenerative Medicine is the vanguard of 21st century health According to Journal: American College of Cardiology

Regenerative Aesthetics is a new field of regenerative medicine that aims to restore and renew the body at the cellular level, dramatically reversing the sands of time and maintaining an aesthetically desirable youthful appearance.

What we really now know is that men and women all over the world want their hair back, they want their sexual organs to work and they want to look and feel their best into their later years.

This brings us to the 3 Regenerative Therapies you should know about.

The first and most widely known of these regenerative therapies is Platelet Rich Plasma or PRP which utilizes your own Blood Plasma and Platelets in a concentrated form to activate the healing cascade. Recruiting your own innate Stem Cells for accelerated wound healing and tissue regeneration.

Known as Liquid Gold, your platelets and plasma have been shown to rejuvenate the

Unfortunately, we are finding clinically that not all PRP is created equally. In fact, some people have a very low concentration of these regenerative growth factors or a high amount of inflammatory cytokines resulting in inconsistencies from person to person, session to session. As PRP continues to get more popular in the mainstream, we find it important to share some of the newer, more optimal Regenerative Technologies that have been emerging.

Which leads us to... The second regenerative therapy you should know about.

Stem Cell Growth factors & Cytokines. Sourced from Bone Marrow Mesenchymal Stem Cells (MSC's) however, they do not contain any actual stem cells or DNA. Growth factors are naturally occurring proteins in your body that regulate cellular growth, healing, proliferation and differentiation under controlled conditions and play a role in cellular communication. They are master bio-signals acting as command and control over your body's natural healing processes and modulation of inflammation.

It has been shown that cells in aging skin generate less growth factors than cells in youthful skin. For example, by the time you are 50, on average 4% of these regenerative bone marrow MSCs are in circulation compared to what you had when you were in your teens. Hence, we age because we damage faster than we repair in our later years.

By simply adding concentrated MSC Growth factors & Cytokines to our Regenerative Therapies we can consistently improve hair loss, skin rejuvenation, collagen growth, sexual organ function, and more. We know for a fact that daily use of skin care products containing stable growth factors and cytokines help reduce the appearance of fine lines & wrinkles and improve skin tone & texture.

Lastly, and most importantly is the latest frontier and the 3rd regenerative therapy you should know about.

The Future of Regenerative Medicine... Known as Stem Cell Exosomes. Science is showing us that the optimal way to provide true stem cell therapy is to directly provide the cell bio-signals in high concentrations. After all, the signaling is what we really require to regenerate a normal healthy physiology.

Exosomes are regarded as the purest form of cellular therapy available today, providing a safe and anti-inflammatory environment for healing and repairing.

The AABB recently reported that up to one in three people in the U.S. could benefit from regenerative medicine.

At Rejuvenate 528 Regenerative Aesthetics Medical Spa, we can include exosomes for enhanced wellness to the majority of our Regenerative Aesthetic Services. This can benefit your overall health and vitality as this is reversing challenges of Inflammation!

Beauty radiates and vibrates at different frequencies in everyone I see! We love to uplift and Rejuvenate both the inner vitality and the outer Radiance of all of our patients and clients. They come for the personal attention and integrative approach using regenerative medicine modalities with ancient technologies. PA Sheri Suiter

Tap into your own healing potential with these types of bio-hacking technologies to enhance your regenerative potential and get the results you truly desire. Live longer, stronger and younger.

Book a consultation for the following Regenerative procedures:

*Medical Microneedling*Vampire Facial*Liquid Facelift*Breastlift*O-Shot*P-Shot*Penile Enhancement*Hair Restoration*Stretch mark & scar repair*Hand Rejuvenation*Joint Inflammation*Overall Vitality & Wellness

Sheri Suiter CLT, MS, PA-C, Founder of Rejuvenate 528 Regenerative Aesthetics Medical Spa in Sarasota, FLRejuvenate528.com

Continue reading here:
Discover The Latest Frontier in Anti-aging Medicine and 3 Regenerative Therapies You Should Know... - YourObserver.com